早期宫颈残端癌腹腔镜与开腹手术应用举宫杯的临床比较分析

目的:比较评估腹腔镜与开腹手术治疗宫颈残端癌的临床疗效及举宫杯的应用价值。方法:将67例早期宫颈癌(ⅠA~ⅡA期)患者随机分为腹腔镜组(n=32)与开腹组(n=35),观察两组患者临床病理资料、术中情况、术后恢复及随访情况等指标。结果:腹腔镜组术中出血量、手术时间、术后康复指标(术后下床活动早、排气时间短、无明显发热)、住院时间优于开腹组(P<0.05);两组术后并发症发生率、复发率差异无统计学意义(P>0.05),但腹腔镜组术后生活质量明显提高(P<0.05)。结论:腹腔镜手术治疗宫颈残端癌的疗效优于开腹手术,明显提高了患者的术后生存质量,值得进一步推广。术中应用举宫杯可使手术更加安全、快捷。     

腹腔镜与开腹宫颈癌根治术治疗早期宫颈癌的 近期疗效对比分析

目的:对比腹腔镜与开腹宫颈癌根治术治疗早期宫颈癌的临床效果。方法:选取2014年5月至2018年5月收治的160例早期宫颈癌患者作为研究对象。根据治疗方案将患者分为两组,A组(n=74)行腹腔镜宫颈癌根治术,B组(n=86)行开腹宫颈癌根治术。比较两组手术时间、术中出血量、切除淋巴结数量、宫旁组织切除长度、阴道切除长度、并发症发生率、术后肠功能恢复时间、术后住院时间、术后住院费用等指标。结果:A组术中出血量、肛门排气时间、术后住院时间、输血比例、并发症发生率优于B组;B组手术时间、术后住院费用优于A组,差异有统计学意义(P<0.05)。两组切除范围差异无统计学意义(P>0.05)。结论:腹腔镜下宫颈癌根治术的治疗效果与开腹手术相当,具有术中出血少、术后康复快、并发症少及术后胃肠功能恢复时间、尿管留置时间、住院时间短等优点,手术安全可靠,值得推广。     

PK钳联合举宫杯在腹腔镜阔韧带子宫肌瘤切除术中的应用价值

目的:探讨PK钳联合举宫杯在腹腔镜阔韧带子宫肌瘤切除术中的应用价值。方法:自2011年3月为12例患者采用PK钳联合举宫杯行腹腔镜子宫阔韧带子宫肌瘤切除术(研究组),并与2009年3月至2011年3月18例腹腔镜阔韧带子宫肌瘤切除术(对照组)进行对比研究。结果:两组患者无一例发生泌尿系统损伤,与传统腹腔镜手术相比,研究组手术时间短(t=-9.580,P=0.000)、中转开腹率低(χ2=9.21,P=0.017)、术后病率低(χ2=3.92,P=0.043)、出血量少(t=-15.120,P=0.000)。结论:腹腔镜阔韧带子宫肌瘤切除术中联合应用PK钳与举宫杯安全、可行,可显著提高手术效果,减少出血量,降低中转开腹率及手术风险与难度。     

腹腔镜下广泛子宫切除加盆腔淋巴结清扫术与开腹手术的比较

目的通过比较腹腔镜与开腹广泛子宫切除及盆腔淋巴结清扫,探讨腹腔镜技术在妇科宫颈癌根治术中的可行性及应用价值。方法将2010年6月至2012年10月,于本院就诊的128例宫颈癌患者．在自愿原则下分为腹腔镜组和开腹组,探讨手术获取阴道长度及宫旁长度、淋巴结数、手术时间、术中出血量、肛门排气时间、留置尿管时间、盆腔引流液量、体温恢复正常时间、术后住院时间、术中及术后并发症、术后随访等方面的数据差异。结果腹腔镜组与开腹组在数据差异上具有统计学意义（P〈0．05）。结论腹腔镜广泛子宫切除及盆腔淋巴结清扫术在治疗早期宫颈癌的疗效上,与开腹手术相当,可作为早期子宫颈癌手术治疗的选择术式之一,值得推广。     

免气腹腹腔镜卵巢成熟畸胎瘤剥除术的应用

目的探讨免气腹腹腔镜在卵巢成熟畸胎瘤剥除术中的应用价值。方法我院2007年1月～2009年1月38例成熟畸胎瘤,分别采取气腹腹腔镜手术(n=18)和免气腹腔镜手术(n=20),比较免气腹与气腹腹腔镜的手术时间、术中出血量、术中畸胎瘤破裂率及术后病率。结果2组手术均无术中、术后并发症发生。免气腹组手术时间(78.0±15.6)min,显著短于气腹组(91.9±14.4)min(t=-2.844,P=0.007);免气腹组术中出血量(59.2±18.4)ml,显著少于气腹组(76.1±22.8)ml(t=-2.526,P=0.016);免气腹组畸胎瘤的破裂率为5.0%(1/20),气腹组为33.3%(6/18),差异有统计学意义(P=0.038)。2组术后病率均为0。结论免气腹腹腔镜手术治疗卵巢良性畸胎瘤具有适应证广、操作简单等优点,且其腹腔外剥除的手术方法能有效地防止术中囊肿破裂等并发症的发生,具有广泛的应用前景。     

腹腔镜与开腹手术行宫颈癌根治术临床效果对比分析

目的比较腹腔镜与常规开腹手术行宫颈癌根治术临床疗效和应用体会。方法将46例早期宫颈癌患者随机分为腹腔镜组(24例)和开腹手术组(22例)。腹腔镜组行腹腔镜下宫颈癌切除,开腹手术组者行传统开腹切除,比较两种术式的手术时间、清扫淋巴结数目、术中出血量、术后肛门排气时间、尿管拔除时间、输血例数、住院时间及术中术后并发症的发生率。结果腹腔镜组在术中出血量、术后肛门排气时间、保留尿管时间、输血例数和住院时间方面指标明显优于开腹手术组,差异有统计学意义(P<0.05)。腹腔镜组术中膀胱损伤、术后肠梗阻并发症发生率显著低于开腹手术组(P<0.05)。腹腔镜组切口全部甲级愈合,开腹手术组有5例乙级愈合。手术时间、清扫淋巴结数目等方面比较差异无统计学意义(P>0.05)。结论腹腔镜下实施广泛全子宫切除加盆腔淋巴结清扫术治疗早期宫颈癌手术创伤小、术后恢复快、术后并发症少。     

举宫杯在腹腔镜子宫切除术中的应用价值

目的:探讨举宫杯在腹腔镜全子宫切除术中的应用价值。方法:将2009年1月至5月我科施行腹腔镜全子宫切除术的80例患者分为两组,I组用举宫杯辅助手术,Ⅱ组用简易举宫器,对比分析两组手术时间、手术难度、术中出血及术后并发症等情况。结果:所有病例均成功完成腹腔镜手术,无一例中转开腹,I组总手术时间和下推膀胱的时间明显短于Ⅱ组(P0.05),术中出血I组明显少于Ⅱ组(P0.05),且手术难度下降,并发症少。结论:举宫杯用于腹腔镜全子宫切除术安全有效,具有明显的优势。     

结直肠癌伴不可切除的同时性肝转移的腹腔镜治疗

目的:探讨结直肠癌伴有同时性不可切除肝转移灶的腹腔镜治疗的可行性及临床应用价值。方法:回顾分析2011年6月至2012年12月31例结直肠癌伴不可切除的同时性肝转移患者的临床资料及随访结果。按原发灶手术切除方式分为两组,A组行开腹手术切除结直肠癌原发灶(n=18),B组行腹腔镜手术(n=13)。术后均采取mFOLFOX6方案化疗。对比分析两组患者手术时间、术中出血量、术后排气时间、术后住院时间、术后接受首次化疗时间及治疗效果。结果:31例均成功施行结直肠癌切除术,腹腔镜组无一例中转开腹及严重并发症发生。术后患者行mFOLFOX6方案化疗至少2个周期。经统计学分析发现,两组患者手术时间、治疗效果差异无统计学意义(P>0.05),但腹腔镜组术中出血量明显减少(P<0.01),术后排气时间明显缩短(P<0.05),术后住院时间明显减少(P<0.05),术后接受首次化疗的时间明显缩短(P<0.05)。结论:对于不可切除的同时性结直肠癌肝转移患者,行腹腔镜原发肿瘤切除是安全、可行的;与开腹手术相比,腹腔镜手术治疗结直肠癌伴不可切除的同时性肝转移,在切除原发灶的手术中具有出血量少、创伤小、术后肠功能恢复快、住院时间明显缩短并促进术后早期化疗等优势。腹腔镜手术对原发肿瘤及转移灶的治疗效果与开腹手术无明显差别,具有良好的临床应用价值。     

腹腔镜淋巴结清扫术在早期妇科肿瘤肥胖患者中的应用

目的:评价腹腔镜广泛子宫切除术加双侧盆腔、腹主动脉旁淋巴结清扫术治疗妇科恶性肿瘤患者的应用价值。方法:回顾分析2009年6月至2013年9月为20例子宫内膜癌、宫颈癌患者行腹腔镜手术的临床资料,观察手术时间、术中出血量、切除淋巴结数量、术后肛门排气时间及术后并发症等指标,并与同期开腹手术进行对比分析。结果:20例腹腔镜手术均顺利完成,无一例中转开腹。两组手术时间、术中失血量、术后肛门排气时间、术后下床活动时间、切口感染或脂肪液化率差异均有统计学意义(P<0.01),清扫淋巴结数量、宫旁或阴道切除范围差异无统计学意义(P>0.01)。术后随访2~3年,两组患者均无复发。结论:相较传统开腹手术,腹腔镜手术具有患者创伤小、并发症少、术后康复快等优点,腹腔镜广泛子宫切除术加盆腔淋巴结切除术治疗肥胖早期妇科恶性肿瘤患者是安全、可行的。     

腹腔镜下保留盆腔神经功能的宫颈癌根治术近期疗效的比较研究

目的探讨腹腔镜下保留盆腔神经丛的根治性子宫切除术(laparoscopic nerve-sparing radical hysterectomy,LNSRH)的可行性、安全性。方法 2009年2月~2010年4月对87例腹腔镜下宫颈癌根治术进行了前瞻性非随机对照研究,其中LNSRH组41例,腹腔镜下根治性子宫切除(laparoscopic radical hysterectomy,LRH)46例(LRH组),比较2组手术时间、出血量、清扫淋巴结数及术后膀胱功能恢复等。结果 2组均顺利完成手术,2组术中出血量、淋巴结清扫数目、阴道和宫旁切除长度上无明显差异(P=0.233,0.309,0.310,0.075)。LNSRH组手术时间(151.1±19.2)min显著长于LRH组(124.3±24.4)min(t=5.645,P=0.000)。LNSRH组尿潴留2例,LRH组8例,2组尿潴留发生率无统计学差异(χ2=2.220,P=0.136)。2组84例随访2~14个月,均存活,LNSRH组无复发,LRH组复发1例。结论 LNSRH治疗早期宫颈癌安全可行。     

子宫动脉栓塞治疗术治疗子宫肌瘤的临床应用

目的探讨子宫动脉栓塞治疗术(UAE)治疗子宫肌瘤的临床应用。方法对46例子宫肌瘤患者进行子宫动脉栓塞治疗,观察术后反应和症状变化,术后3、6、12个月进行随访分析疗效。结果造影显示双侧子宫动脉供血17例(占37%),一侧供血为主24例(占52%),单纯一侧供血5例(占11%)。肿瘤平均缩小率:3个月34%,6个月48%,12个月56%,其中5例肌瘤消失。46例患者临床症状均有不同程度改善,无严重并发症。结论子宫动脉栓塞术治疗子宫肌瘤是一种安全有效的微创治疗方法。     

Pelvic organ prolapse after uterine artery embolization for uterine myoma

Uterine artery embolization (UAE) is gaining popularity as a treatment modality in patients with symptomatic uterine fibroids who do not desire fertility. Complications of this procedure can be serious and disabling. A 50-year-old woman presented with stage II uterovaginal prolapse after UAE for symptomatic uterine fibroids. Pelvic organ prolapse developed 16 months after the initial procedure. Surgical correction was performed. This is the first case report of pelvic organ prolapse after UAE. Normal prior gynecological examinations, and absence of pelvic pressure symptoms, indicate that pelvic organ prolapse had occurred subsequent to UAE.     

改良式子宫捆绑术在剖宫产宫缩乏力出血中的应用

目的探讨改良式子宫捆绑术在剖宫产宫缩乏力出血中的应用。方法选取剖宫产宫缩乏力出血患者98例,随机分为改良组和常规组,分别采用改良式子宫捆绑术和传统子宫捆绑术,观察两组疗效。结果治疗前,两组血常规指标比较差异无统计学意义(P0.05)。治疗后,改良组血常规优于常规组,差异有统计学意义(P0.05)。改良组总有效率高于常规组,出血量低于常规组,差异有统计学意义(P0.05)。结论改良式子宫捆绑式可有效提高临床治疗效果,可在临床推广和应用。     

Recurrent uterine rupture after hysterescopic resection of the uterine septum

INTRODUCTIONUterine rupture after hysteroscopic septum resection is a rare complication, and its frequency is reported to be approximately 1–2.7%. Uterine perforation and monopolar resection during hysteroscopy are well-known risk factors for subsequent uterine rupture during pregnancy.PRESENTATION OF CASEWe present a case of recurrent uterine ruptures during consecutive pregnancies in a patient who had undergone hysteroscopic septum resection for recurrent pregnancy loss.DISCUSSIONRecurrent uterine rupture due to hysteroscopic septum resection in pregnancy is a very rare condition. In the present case we noted that the first two uterine ruptures resulted from uterine contractions; however, the third rupture occurred spontaneously and earlier in gestation. As each uterine rupture occurred earlier than the rupture in the previous gestation, a history of uterine rupture during pregnancy should raise provider suspicion about the possibility of earlier uterine rupture recurrence.CONCLUSIONUterine rupture may occur in pregnancies after hysteroscopic resection of the uterine septum. However, if a patient has a history of uterine rupture during previous pregnancies, the risk of uterine rupture may increase for earlier gestational ages in subsequent pregnancies. The patient must be informed about both the risks of uterine rupture during pregnancy after hysteroscopic septum resection and that recurrent ruptures may occur at earlier gestational weeks than during previous pregnancies.     

Pelviscopic uterine surgery

Summary About 15–20% of the time uterine surgery via laparotomy is replaced in our department by operative pelviscopy. Of these, in reference to myoma surgery, about 70% were tackled with operative pelviscopy and a laparotomy was avoided.This allows the preservation of the uterus, especially for those women who desire to bear children in the future. Organ-preserving, minimally invasive surgery is the current accepted operative ideal. Postoperative sequelae like adhesion formation, subacute intestinal obstruction, and chronic abdominal pain are thus decreased.The importance of correct and safely functioning equipment and instruments cannot be overstressed for optimal results. A closed drain, i.e., the Robinson drainage system, can be kept in place for at least 12–24 h to check the postoperative ooze. In two cases of extensive ooze, repeat pelviscopy was performed within 12 h and hemostasis was achieved by the use of endosutures and endocoagulation.     

Dysfunctional uterine bleeding

Dysfunctional uterine bleeding is defined as abnormal uterine bleeding in the absence of organic disease. It is the result of anovulation or the abnormal local production of prostaglandins, and in each case the primary fault is inappropriate hormone formation. There are two approaches to diagnosis. The traditional one is primarily concerned with the exclusion of cancer of the endometrium; this concern results in the frequent resort to uterine curettage. The second approach is to limit curettage to patients whose symptoms are not ameliorated by medical therapy. The aim of medical treatment is either to produce secretory change in the endometrium or to decrease the formation of uterine prostaglandins. Intermittent progesterone treatment is used to cause secretory changes in the endometrium. Decreased production of the prostaglandins is achieved indirectly by causing atrophy of the endometrium or directly through the use of prostaglandin synthetase inhibitors. Surgery in the form of dilatation and curettage has no long-term therapeutic effect; hysterectomy is definitive therapy.     

Giant uterine leiomyoma

Uterine leiomyomas represent the most common benign tumors of the female reproductive tract. Giant uterine leiomyomas are very rare neoplasms and represents a great diagnosis and therapeutic challenge. This article illustrates a case of a 45-year old woman presented to our surgery department with a 10-month history of progressive increasing abdominal size, back pain, vague abdominal pressure sensations, weight loss, constipation and urinary frequency. Physical examination, laboratory evaluation, transabdominal ultrasound and computed tomography scanning suggested a giant abdominopelvic mass. Abdominal supracervical hysterectomy with bilateral salpingo-oophorectomy was performed. Histologically, the specimen was a 18.1 Kg uterine leiomyoma measuring 33/28/22 cm. The patient's postoperative course was uneventful and she was discharged from the hospital on the sixth postoperative day.